Setterwalls assists Klaria Pharma Holding AB (publ) in connection with a rights issue

Setterwalls assists Klaria Pharma Holding AB (publ), listed on Nasdaq First North Growth Market, in connection with a rights issue of approximately SEK 59 million. Erik Penser Bank is the financial advisor in connection with the rights issue.

Klaria is a Swedish listed pharmaceutical company that develops innovative and rapid-acting products. By combining patented technology of a film that attaches to the oral mucosa and well proven pharmaceuticals, Klaria has developed a drug distribution concept with many benefits and potential uses.